HARROW, INC.

Nasdaq:HROW

Pharmaceutical Preparations·NASHVILLE, TN

CEO

Baum Mark L

CFO

Boll Andrew R.

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/2/26	→
10-Q	Q3 2025	9/30/25	11/10/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	3/27/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

Earnings Releases (8-K)

24 shown

Filed	Period
3/2/26	Q1 FY2026	→
2/2/26	Q4 FY2026	→
11/10/25	Q3 FY2025	→
8/11/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
3/27/25	Q1 FY2025	→
↓

News (8-K)

56 shown

Filed	Type	Description
11/18/25	Acquisition	Completion of Acquisition or Disposition of Assets	→
10/6/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/1/25	Other	8-K Filing	→
9/29/25	Agreement	Entry into a Material Definitive Agreement	→
9/26/25	Reg FD	Regulation FD Disclosure	→
9/26/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
6/20/25	S-8	S-8	→
7/19/23	424B5	424B5	→
7/18/23	424B5	424B5	→
12/19/22	424B5	424B5	→
12/16/22	FWP	FWP	→
12/14/22	424B5	424B5	→
↓

Filing History(838 filings)

TypeDateAccessionPeriodSize

Mar 5, 2026

0001493152-26-0089904

Mar 3, 2026

12.1 KB

Mar 3, 2026

0001493152-26-0087084

Feb 27, 2026

6.9 KB

10-K

Mar 2, 2026

0001493152-26-00856210-K

Dec 31, 2025

13.3 MB

8-K

Mar 2, 2026

0001493152-26-0085528-K

Mar 2, 2026

8.3 MB

Feb 2, 2026

0001493152-26-0046524

Jan 30, 2026

8.1 KB

Feb 2, 2026

0001493152-26-0046513

Jan 30, 2026

13.6 KB

8-K

Feb 2, 2026

0001493152-26-0046358-K

Jan 30, 2026

310.0 KB

Jan 8, 2026

0001493152-26-0009654

Jan 6, 2026

7.3 KB

Dec 16, 2025

0001493152-25-0280384

Dec 12, 2025

8.8 KB

Dec 16, 2025

0001493152-25-0280364

Dec 12, 2025

8.8 KB

8-K

Nov 18, 2025

0001493152-25-0239888-K

Nov 17, 2025

269.8 KB

10-Q

Nov 10, 2025

0001493152-25-02156210-Q

Sep 30, 2025

9.9 MB

8-K

Nov 10, 2025

0001493152-25-0215558-K

Aug 11, 2025

16.5 MB

Oct 10, 2025

0001493152-25-0178353

Oct 6, 2025

13.5 KB

25-NSE

Oct 10, 2025

0001354457-25-001012

—

3.2 KB

25-NSE

Oct 8, 2025

0001354457-25-001004

—

3.2 KB

8-K

Oct 6, 2025

0001493152-25-0170078-K

Oct 6, 2025

282.5 KB

8-K/A

Oct 1, 2025

0001493152-25-0164738-K/A

Sep 24, 2025

1.0 MB

8-K

Sep 29, 2025

0001493152-25-0158788-K

Sep 26, 2025

257.5 KB

8-K

Sep 26, 2025

0001493152-25-0157128-K

Sep 26, 2025

42.2 MB

8-K

Sep 26, 2025

0001493152-25-0150548-K

Sep 24, 2025

313.9 KB

8-K

Sep 19, 2025

0001493152-25-0142428-K

Sep 17, 2025

267.3 KB

8-K

Sep 12, 2025

0001493152-25-0132688-K

Sep 8, 2025

2.2 MB

Sep 9, 2025

0001641172-25-027002

Sep 1, 2025

5.7 KB

Sep 9, 2025

0001641172-25-027000

Sep 1, 2025

12.2 KB

25 filings shown

Filed	Form	Description
4/25/25	DEFA14A	DEFA14A	→
4/25/25	DEF 14A	DEF 14A	→
4/26/24	DEFA14A	DEFA14A	→
4/26/24	DEF 14A	DEF 14A	→
4/28/23	DEFA14A	DEFA14A	→
4/28/23	DEF 14A	DEF 14A	→
↓

HARROW, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(838 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/5/26	4	4	→
3/3/26	4	4	→
2/2/26	4	4	→
2/2/26	3	3	→
1/8/26	4	4	→
12/16/25	4	4	→
↓

Filed	Form	Description
10/10/25	25-NSE	25-NSE	→
10/8/25	25-NSE	25-NSE	→
4/7/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/21/22	CERT	CERT	→
12/20/22	8-A12B	8-A12B	→
12/16/22	305B2	305B2	→
↓